8th Circ. Reinstates Investors' Claims Against KV Pharma

Law360, New York (June 4, 2012, 8:59 PM EDT) -- The Eighth Circuit on Monday gave new life to a shareholder class action against KV Pharmaceutical Co., reviving claims that the drugmaker misled investors by failing to disclose myriad problems with the U.S. Food and Drug Administration that ended in criminal pleas.

A three-judge panel held that the investors, led by the Norfolk County Retirement System and the State-Boston Retirement System, could pursue their allegations that they were misled by KV's failure to disclose its problems with the FDA and that they had a right to...
To view the full article, register now.